EUVIMEDEUVIMED entdecken
Systematische Übersicht

Current evidence and indications for left atrial appendage closure

Masaya Shinohara, Mike Saji, Hideki Koike, Hiroshi Ohara, Yoshinari Enomoto, Rine Nakanishi, Tadashi Fujino, Takanori Ikeda

Journal of Cardiology · 2025-04 · 85 (4) · 268-274

DOI: 10.1016/j.jjcc.2025.01.014 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cardiology, 2025-04. Verfasst von Masaya Shinohara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Helmsley Electrophysiology Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Division of Cardiovascular M…. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Stroke. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF) is the most common arrhythmia worldwide and its prevalence increases with age. The main and most severe complication of AF is ischemic stroke, yet an estimated 50 % of eligible patients cannot tolerate or are contraindicated to receive oral anticoagulation (OAC). In patients with AF, the left atrial appendage (LAA) is the main source of thrombus formation. Percutaneous LAA closure (LAAC) has emerged over the past two decades as a valuable alternative to OAC for reducing the risk of strokes and systemic embolisms in patients with AF who cannot tolerate long-term OAC. With newer generation devices such as the Watchman (Boston Scientific, Natick, MA, USA) and Amulet (Abbott, Abbott Park, IL, USA) gaining approval from the US Food and Drug Administration in recent years, the safety and efficacy of LAAC in specific populations intolerant to OAC have increased and more patients are being treated. This systematic review provides the indications for LAAC and the evidence for evaluating the use of the currently available device therapies. We also examine the current unsolved problems with patient selection and postprocedural antithrombotic regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageAtrial FibrillationStrokeHumansAnticoagulantsSeptal Occluder DevicePatient SelectionCardiac Surgical ProceduresLeft Atrial Appendage Closure

Stichwörter der Autor:innen

AmuletAtrial fibrillationLeft atrial appendage closureWatchman

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Helmsley Electrophysiology Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of M…
  • Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan. Electronic address: mikesaji8@gmail.com.
  • Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan.
  • Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan; Division of Cardiology, National Center for Global Health and Medicine Hospital, Tokyo, Japan.

Zitieren

APA

Shinohara, M., Saji, M., Koike, H., Ohara, H., Enomoto, Y., Nakanishi, R., Fujino, T., & Ikeda, T. (2025). Current evidence and indications for left atrial appendage closure. Journal of Cardiology, 85(4), 268-274. https://doi.org/10.1016/j.jjcc.2025.01.014

Vancouver

Shinohara M, Saji M, Koike H, Ohara H, Enomoto Y, Nakanishi R, et al. Current evidence and indications for left atrial appendage closure. Journal of Cardiology. 2025;85(4):268-274. doi:10.1016/j.jjcc.2025.01.014

BibTeX
@article{Shinohara2025,
  author = {Shinohara, Masaya and Saji, Mike and Koike, Hideki and Ohara, Hiroshi and Enomoto, Yoshinari and Nakanishi, Rine and Fujino, Tadashi and Ikeda, Takanori},
  title = {Current evidence and indications for left atrial appendage closure},
  journal = {Journal of Cardiology},
  year = {2025},
  volume = {85},
  number = {4},
  pages = {268--274},
  doi = {10.1016/j.jjcc.2025.01.014}
}
Kostenlos starten →